John Johnson, CEO & President at SAVIENT PHARMACEUTICALS INC (SVNT), bought 5,000 shares at $2.30 ($12K) on 2011-11-21, disclosed to the SEC on 2011-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| XERS | SELL | 2025-12-19 | $978K | — | Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| XERS | SELL | 2025-08-15 | $787K | — | Filing → |